Skip to content

NVIDIA BioNeMo

NVIDIA BioNeMo is a generative AI framework for drug discovery, accelerating biomolecular model development and deployment.

Paid · Web, API

stork
I am a flat drawing.
One flat drawing and one typed sentence.
This drawing was never animated.
A photo, a cartoon, a painting or a 3D character. From 10 cents a minute. Free to try.
Make a photo talkDevelopers: there is an API

What is NVIDIA BioNeMo?

NVIDIA BioNeMo is a generative AI framework tool developed by NVIDIA that enables drug researchers, scientists, and developers to accelerate AI-driven drug discovery and biomolecular model development. It integrates protein language models and OpenFold to facilitate biomolecular prediction and generation processes.

Key Features of NVIDIA BioNeMo

NVIDIA BioNeMo provides a comprehensive suite of tools and pre-trained models designed for AI-driven drug discovery and computational biology. The platform leverages NVIDIA's GPU technologies to optimize performance for demanding biomolecular AI workloads.

  • Integration of protein language models and OpenFold for structural biology.
  • Framework for training and deploying large-scale biomolecular models.
  • API available for programmatic access and integration into existing workflows.
  • Prediction of 3D protein structures and molecular properties.
  • Generation of novel protein sequences and molecules.
  • Support for virtual screening and molecular docking simulations.
  • Leverages leading GPU technologies for high-performance AI processing.
  • Comprehensive range of AI software and tools for life sciences research.

Who Should Use NVIDIA BioNeMo?

NVIDIA BioNeMo is designed for professionals and organizations engaged in advanced biomolecular research and drug development, seeking to leverage AI for accelerated discovery processes.

  • Drug researchers and scientists: For accelerating drug discovery workflows and developing novel therapeutics.
  • Developers and data teams in pharmaceutical and biotech organizations: For training and deploying large-scale biomolecular models.
  • Biopharma organizations: For predicting 3D protein structures, molecular properties, and generating new biomolecules.
  • Computational biologists: For genomic and proteomic data analysis, identifying patterns and correlations.

How to Use NVIDIA BioNeMo

NVIDIA BioNeMo functions as a cloud service and framework, enabling researchers to develop and deploy AI applications for biomolecular modeling. Users can access pre-trained models or train custom models on NVIDIA's optimized infrastructure.

  1. Access the NVIDIA BioNeMo cloud service or framework via the NVIDIA Clara platform.
  2. Utilize pre-trained biomolecular models, such as ESMFold or OpenFold, for specific prediction tasks.
  3. Train custom large-scale biomolecular models using the provided framework and NVIDIA GPU resources.
  4. Deploy AI applications for biomolecular prediction and generation via the BioNeMo API.
  5. Integrate BioNeMo's capabilities into existing research workflows for tasks like virtual screening and molecular docking.

NVIDIA BioNeMo Pricing & Plans

The NVIDIA BioNeMo Framework is free to use, providing access to programming tools, packages, and optimized pre-trained biomolecular models. For production-level workloads and higher performance requirements, NVIDIA offers paid enterprise tiers.

  • Free Tier: Available for personal developer accounts using NVIDIA NIM endpoints, subject to a global hard cap of 40 requests per minute (RPM).
  • NVIDIA AI Enterprise Tier: Paid tier designed for production workloads requiring higher RPM (e.g., 200 RPM), with options to host NIM containers locally on user hardware or through an NVIDIA AI Enterprise subscription.

Pros

  • Comprehensive, end-to-end AI toolset optimized for NVIDIA GPUs.
  • Seamless integration with major cloud platforms and AI frameworks like TensorFlow and PyTorch.
  • Achieved enterprise-grade security and compliance, including HIPAA alignment, ISO status, and SOC2 status.
  • Accelerates AI-driven drug discovery workflows and preclinical development.
  • Provides a robust framework for training and deploying large-scale biomolecular models.
  • Offers a free tier for personal developer accounts, enabling initial exploration.

Cons

  • Steep learning curve reported for teams new to AI workflows in drug discovery.
  • Potential cost concerns for smaller businesses due to enterprise-tier pricing.
  • Mixed feedback regarding the responsiveness and quality of support services.
  • Tight coupling to NVIDIA-certified hardware may limit flexibility for organizations not using NVIDIA infrastructure.
  • The free tier has a global hard cap of 40 requests per minute (RPM), which may be insufficient for larger projects.

NVIDIA BioNeMo vs Competitors

NVIDIA BioNeMo is positioned as a leading platform for AI-driven drug discovery, leveraging NVIDIA's expertise in GPU-accelerated computing. Its comprehensive suite of optimized models and frameworks aims to reduce preclinical development time and cost.

NVIDIA BioNeMo

Paid · Web, API

Enjoying this? Get one like it in your inbox each morning.

one email a day · unsubscribe in two clicks · no third-party tracking